IFNG and Miyoshi myopathy: After the first booster (vd3), levels of both IL-2 and IFN-γ correlated with S1-specific IgG, and at the time of BTI (between vd3 and vd4), when antibodies had already declined in MM patients, IFN-γ levels were still present in considerable levels, and this remained so up to one month after vd4 (Supplementary Figure S8A–H).